Fuyong Du

690 total citations
17 papers, 548 citations indexed

About

Fuyong Du is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Fuyong Du has authored 17 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Fuyong Du's work include Diabetes Treatment and Management (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Pancreatic function and diabetes (4 papers). Fuyong Du is often cited by papers focused on Diabetes Treatment and Management (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Pancreatic function and diabetes (4 papers). Fuyong Du collaborates with scholars based in United States and Belgium. Fuyong Du's co-authors include Keith T. Demarest, Yin Liang, June Xu, David Polidori, Kiichiro Ueta, Yi Liu, Tonya Martin, Barbara R. Conway, Yasuaki Matsushita and Chiaki Kuriyama and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes.

In The Last Decade

Fuyong Du

17 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuyong Du United States 11 258 238 194 147 79 17 548
Lawrence J. Kennedy United States 13 571 2.2× 353 1.5× 225 1.2× 185 1.3× 118 1.5× 23 883
Hideki Fujikura Japan 5 418 1.6× 271 1.1× 246 1.3× 94 0.6× 73 0.9× 6 598
Torsten Haack Germany 15 358 1.4× 288 1.2× 158 0.8× 107 0.7× 115 1.5× 27 663
Hirotaka Kimata Japan 11 411 1.6× 260 1.1× 271 1.4× 158 1.1× 74 0.9× 12 744
David B. Rawlins United States 11 269 1.0× 231 1.0× 178 0.9× 199 1.4× 57 0.7× 17 614
Minoru Tsuda-Tsukimoto Japan 9 284 1.1× 193 0.8× 180 0.9× 169 1.1× 74 0.9× 12 615
Ellen V. Cryan United States 10 160 0.6× 214 0.9× 115 0.6× 56 0.4× 21 0.3× 13 426
Hirotoshi Kakuta Japan 14 109 0.4× 221 0.9× 155 0.8× 42 0.3× 42 0.5× 25 531
Hitoshi Hagita United States 9 230 0.9× 191 0.8× 135 0.7× 93 0.6× 43 0.5× 9 408
Denise P. Milot United States 12 132 0.5× 193 0.8× 204 1.1× 50 0.3× 34 0.4× 13 436

Countries citing papers authored by Fuyong Du

Since Specialization
Citations

This map shows the geographic impact of Fuyong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuyong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuyong Du more than expected).

Fields of papers citing papers by Fuyong Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuyong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuyong Du. The network helps show where Fuyong Du may publish in the future.

Co-authorship network of co-authors of Fuyong Du

This figure shows the co-authorship network connecting the top 25 collaborators of Fuyong Du. A scholar is included among the top collaborators of Fuyong Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuyong Du. Fuyong Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wang, Xinkang, et al.. (2023). Antithrombotic Effects of the Novel Small-Molecule Factor XIa Inhibitor Milvexian in a Rabbit Arteriovenous Shunt Model of Venous Thrombosis. SHILAP Revista de lepidopterología. 7(2). e97–e104. 3 indexed citations
2.
Xu, Guozhang, Fuyong Du, Gee‐Hong Kuo, et al.. (2020). 5,5-Difluoro- and 5-Fluoro-5-methyl-hexose-based C-Glucosides as potent and orally bioavailable SGLT1 and SGLT2 dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(17). 127387–127387. 10 indexed citations
3.
Xu, Guozhang, Michael D. Gaul, Fengbin Song, et al.. (2019). Discovery of potent and orally bioavailable indazole-based glucagon receptor antagonists for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry Letters. 29(20). 126668–126668. 3 indexed citations
4.
Du, Fuyong, et al.. (2019). Pharmacological Profile of JNJ-64179375: A Novel, Long-Acting Exosite-1 Thrombin Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 371(2). 375–384. 1 indexed citations
5.
Kuo, Gee‐Hong, Micheal D. Gaul, Yin Liang, et al.. (2018). Synthesis and biological evaluation of benzocyclobutane-C-glycosides as potent and orally active SGLT1/SGLT2 dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(7). 1182–1187. 29 indexed citations
6.
Du, Fuyong, Simon A. Hinke, Cassandre Cavanaugh, et al.. (2018). Potent Sodium/Glucose Cotransporter SGLT1/2 Dual Inhibition Improves Glycemic Control Without Marked Gastrointestinal Adaptation or Colonic Microbiota Changes in Rodents. Journal of Pharmacology and Experimental Therapeutics. 365(3). 676–687. 25 indexed citations
7.
Liu, Jianying, Tonya Martin, Sanath K. Meegalla, et al.. (2018). FFAR1 Agonism Restores Insulin Secretion in Rodents, Human Islets, and Diabetic Monkeys. Diabetes. 67(Supplement_1). 1 indexed citations
8.
Xu, Guozhang, Michael D. Gaul, Gee‐Hong Kuo, et al.. (2018). Design, synthesis and biological evaluation of (2S,3R,4R,5S,6R)-5-fluoro-6-(hydroxymethyl)-2-aryltetrahydro-2H-pyran-3,4-diols as potent and orally active SGLT dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(21). 3446–3453. 11 indexed citations
9.
Zhang, Xuqing, Zhihua Sui, Jack A. Kauffman, et al.. (2017). Evaluation of anti-diabetic effect and gall bladder function with 2-thio-5-thiomethyl substituted imidazoles as TGR5 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 27(8). 1760–1764. 14 indexed citations
10.
Zhang, Xuqing, Mark J. Wall, Zhihua Sui, et al.. (2017). Discovery of Orally Efficacious Tetrahydrobenzimidazoles as TGR5 Agonists for Type 2 Diabetes. ACS Medicinal Chemistry Letters. 8(5). 560–565. 9 indexed citations
11.
Qi, Jenson, Wensheng Lang, Margery A. Connelly, et al.. (2016). Metabolic tracing of monoacylglycerol acyltransferase-2 activity in vitro and in vivo. Analytical Biochemistry. 524. 68–75. 1 indexed citations
12.
Du, Fuyong, Anthony Virtue, Hong Wang, & Xiaofeng Yang. (2013). Metabolomic analyses for atherosclerosis, diabetes, and obesity. Biomarker Research. 1(1). 17–17. 53 indexed citations
13.
Liang, Yin, Kenji Arakawa, Kiichiro Ueta, et al.. (2012). Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models. PLoS ONE. 7(2). e30555–e30555. 200 indexed citations
14.
Semple, Graeme, Juerg Lehmann, Albert Ren, et al.. (2011). Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile. Bioorganic & Medicinal Chemistry Letters. 22(4). 1750–1755. 39 indexed citations
15.
Jain, Nareshkumar, Jiayi Xu, Ramesh M. Kanojia, et al.. (2009). Identification and Structure−Activity Relationships of Chromene-Derived Selective Estrogen Receptor Modulators for Treatment of Postmenopausal Symptoms. Journal of Medicinal Chemistry. 52(23). 7544–7569. 90 indexed citations
16.
Vassalle, Mario, Leonardo Bocchi, & Fuyong Du. (2006). A slowly inactivating sodium current (INa2) in the plateau range in canine cardiac Purkinje single cells. Experimental Physiology. 92(1). 161–173. 18 indexed citations
17.
Jain, Nareshkumar, Ramesh M. Kanojia, Jiayi Xu, et al.. (2006). Novel Chromene-Derived Selective Estrogen Receptor Modulators Useful for Alleviating Hot Flushes and Vaginal Dryness. Journal of Medicinal Chemistry. 49(11). 3056–3059. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lawrence J. Kennedy Breakdown of academic impact, for papers by Hideki Fujikura Breakdown of academic impact, for papers by Torsten Haack Breakdown of academic impact, for papers by Hirotaka Kimata Breakdown of academic impact, for papers by David B. Rawlins Breakdown of academic impact, for papers by Minoru Tsuda-Tsukimoto Breakdown of academic impact, for papers by Ellen V. Cryan Breakdown of academic impact, for papers by Hirotoshi Kakuta Breakdown of academic impact, for papers by Hitoshi Hagita Breakdown of academic impact, for papers by Denise P. Milot
Rankless by CCL
2026